Chimeric Therapeutics Ltd. (CHM) Price & Analysis

Q: What is Chimeric Therapeutics Ltd.’s market cap?

Chimeric Therapeutics Ltd.’s market cap is AU$9.76M.

Q: When is Chimeric Therapeutics Ltd.’s upcoming earnings report date?

Chimeric Therapeutics Ltd.’s upcoming earnings report date is Aug 28, 2025 which is yesterday.

Q: How were Chimeric Therapeutics Ltd.’s earnings last quarter?

Chimeric Therapeutics Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Q: Is Chimeric Therapeutics Ltd. overvalued?

According to Wall Street analysts Chimeric Therapeutics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Chimeric Therapeutics Ltd. pay dividends?

Chimeric Therapeutics Ltd. does not currently pay dividends.

Q: What is Chimeric Therapeutics Ltd.’s EPS estimate?

Chimeric Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Chimeric Therapeutics Ltd. have?

Chimeric Therapeutics Ltd. has 3,254,558,800 shares outstanding.

Q: What happened to Chimeric Therapeutics Ltd.’s price movement after its last earnings report?

Chimeric Therapeutics Ltd. reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Chimeric Therapeutics Ltd.?

Currently, no hedge funds are holding shares in AU:CHM

Compare

11 Followers

CHM Stock Chart & Stats

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.02

Previous CloseN/A

Volume2.58M

Average Volume (3M)2.05M

Market Cap

AU$9.76M

Enterprise ValueAU$1.97M

Total Cash (Recent Filing)AU$5.07M

Total Debt (Recent Filing)AU$0.00

Price to Earnings (P/E)―

Beta1.74

Next Earnings

Aug 28, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding3,254,558,800

10 Day Avg. Volume3,014,500

30 Day Avg. Volume2,054,362

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Chimeric Therapeutics Ltd. News

Chimeric Therapeutics Releases 2025 Corporate Governance Statement

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has issued an update. Chimeric Therapeutics Ltd. has released its Corporate Governance...

6h ago

CHM

Chimeric Therapeutics Reports Revenue Growth and Reduced Losses

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has issued an update. Chimeric Therapeutics Limited reported a significant increase in...

6h ago

CHM

Chimeric Therapeutics to Host Webinar on Innovative CAR T Therapy

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) just unveiled an announcement. Chimeric Therapeutics Ltd. announced an upcoming webinar featuring...

4d ago

CHM

Chimeric Therapeutics Director Acquires Significant Shareholding

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an announcement. Chimeric Therapeutics Limited has announced a change in...

8d ago

CHM

Chimeric Therapeutics Issues Unquoted Securities

The latest update is out from Chimeric Therapeutics Ltd. ( ($AU:CHM) ). Chimeric Therapeutics Limited has announced the...

22d ago

CHM

Chimeric Therapeutics Expands Market Presence with New ASX Securities Quotation

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) just unveiled an announcement. Chimeric Therapeutics Ltd. announced the quotation of 5,435,254...

22d ago

CHM

Chimeric Therapeutics Advances CHM CDH17 Clinical Trial with Promising Results

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an announcement. Chimeric Therapeutics has advanced its CHM CDH17 clinical...

26d ago

CHM

Chimeric Therapeutics Announces Change in Substantial Holder Interests

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an update. Chimeric Therapeutics Ltd. has announced a change in...

1M ago

CHM

Chimeric Therapeutics Advances Cancer Treatment with Key Milestones and Funding

Chimeric Therapeutics Ltd. ( ($AU:CHM) ) just unveiled an announcement. Chimeric Therapeutics has made significant progress in its...

1M ago

CHM

Chimeric Therapeutics to Issue 11 Million New Securities

The latest update is out from Chimeric Therapeutics Ltd. ( ($AU:CHM) ). Chimeric Therapeutics Limited announced a proposed...

1M ago

CHM

CHM FAQ

What was Chimeric Therapeutics Ltd.’s price range in the past 12 months?

Chimeric Therapeutics Ltd. lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.

What is Chimeric Therapeutics Ltd.’s market cap?

Chimeric Therapeutics Ltd.’s market cap is AU$9.76M.

When is Chimeric Therapeutics Ltd.’s upcoming earnings report date?

Chimeric Therapeutics Ltd.’s upcoming earnings report date is Aug 28, 2025 which is yesterday.

How were Chimeric Therapeutics Ltd.’s earnings last quarter?

Chimeric Therapeutics Ltd. released its earnings results on Feb 28, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.

Is Chimeric Therapeutics Ltd. overvalued?

According to Wall Street analysts Chimeric Therapeutics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Chimeric Therapeutics Ltd. pay dividends?

Chimeric Therapeutics Ltd. does not currently pay dividends.

What is Chimeric Therapeutics Ltd.’s EPS estimate?

Chimeric Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Chimeric Therapeutics Ltd. have?

Chimeric Therapeutics Ltd. has 3,254,558,800 shares outstanding.

What happened to Chimeric Therapeutics Ltd.’s price movement after its last earnings report?

Chimeric Therapeutics Ltd. reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Chimeric Therapeutics Ltd.?

Currently, no hedge funds are holding shares in AU:CHM

Chimeric Therapeutics Ltd. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-180.09%

Trailing 12-Months

Asset Growth

-30.02%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Chimeric Therapeutics Ltd.

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.